The role and prospects of the Fudan classification in precision medicine for triple-negative breast cancer

Cancer Genetics 2026

View at publisher
Authors: Qiuting Yang, Qiuting Yang, Bing Li, Yuan Chen, Huiling Yang
DOI: 10.1016/j.cancergen.2026.01.002
Cited by: 0
References: 136

Fields of Study & Subjects

HER2/EGFR in Cancer Research Breast Cancer Treatment Studies Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Cancer Genetics
Publisher
Elsevier BV
Volume
302-303
Pages
93–106
Publication date
3 January 2026
Language
EN